FAILURE TO FIRST-LINE DIRECT ANTIVIRAL (DAA) TREATMENT OF HCV INFECTION IN AN ITALIAN REAL-LIFE URBAN SETTING

被引:0
|
作者
Di Paolo, D. [1 ]
Rossi, P. [1 ]
Lenci, I. [1 ]
Milana, M. [1 ]
Masetti, C. [1 ]
Santopaolo, F. [1 ]
Lionetti, R. [2 ]
D'Offizi, G. [2 ]
Pellicelli, A. [3 ]
Fondacaro, L. [3 ]
Siciliano, M. [4 ]
Tortora, A. [4 ]
Chiesara, F. [5 ]
Moretti, A. [5 ]
Ceccherini-Silberstain, F. [6 ]
Cento, V. [6 ]
Perno, C. F. [6 ]
Angelico, M. [1 ]
机构
[1] Univ Roma Tor Vergata, Hepatol Unit, Rome, Italy
[2] Ist Nazl Malattie Infett Spallanzani, Hepatol Unit, Rome, Italy
[3] Osped S Camillo Roma, Hepatol Unit, Rome, Italy
[4] Policlin Gemelli, Hepatol Unit, Rome, Italy
[5] Osped S Filippo Neri, Hepatol Unit, Rome, Italy
[6] Univ Roma Tor Vergata, Virol Unit, Rome, Italy
关键词
D O I
10.1016/S0168-8278(16)01472-0
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
SAT-132
引用
收藏
页码:S755 / S755
页数:1
相关论文
共 50 条
  • [1] TREATMENT FAILURE TO FIRST-LINE DIRECT ANTIVIRAL (DAA) IN HCV-RELATED ADVANCED LIVER DISEASE: AN ITALIAN REAL-LIFE URBAN SETTING
    Di Paolo, D.
    Rossi, P.
    Lenci, I.
    Milana, M.
    Masetti, C.
    Santopaolo, F.
    Lionetti, R.
    D'Offizi, G.
    Pellicelli, A.
    Fondacaro, L.
    Siciliano, M.
    Gerardi, V.
    Chiesara, F.
    Moretti, A.
    Ceccherini-Silberstein, F.
    Cento, V.
    Perno, C. F.
    Angelico, M.
    DIGESTIVE AND LIVER DISEASE, 2016, 48 : E2 - E3
  • [2] Real life experience with direct antiviral agent (DAA) treatment of chronic HCV Infection in a Swiss Center
    Bachofner, Jacqueline A.
    Valli, Piero V.
    Kroger, Arne
    Braun, Dominique
    Fehr, Jan
    Mullhaupt, Beat
    Mertens, Joachim C.
    SWISS MEDICAL WEEKLY, 2016, 146 : 19S - 19S
  • [3] "REAL-LIFE"-EXPERIENCE WITH SECOND GENERATION DIRECT ACTING ANTIVIRAL (DAA) TREATMENT IN HCV PATIENTS (N=149)
    Werner, C. R.
    Egetemeyr, D. P.
    Malek, N. P.
    Lauer, U. M.
    Berg, C. P.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S664 - S664
  • [4] Characteristics and retreatment of HCV DAA failure patients: Real-life experience
    Ruiz, I.
    Fourati, S.
    Varaut, A.
    Giovanna, S.
    Francois, M.
    Wlassow, M.
    Poiteau, L.
    Donati, F.
    Soulier, A.
    Stephane, C.
    Mallat, A.
    Pawlotsky, J. -M.
    Hezode, C.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S277 - S278
  • [5] Optimization of direct antiviral agent treatment schedule in hepatitis C virus genotype 3 infection: an Italian, multicentetric experience in real-life setting
    Granata, R.
    Valvano, M. R.
    Donnarumma, L.
    Camera, S.
    Milella, M.
    Andreone, P.
    Messina, V.
    Termite, A. P.
    Cozzolongo, R.
    Santantono, T.
    Tundo, P.
    Ciraci, E.
    Masetti, C.
    Smedile, A.
    Morando, F.
    Morisco, F.
    Caporaso, N.
    Andriulli, A.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S734 - S734
  • [6] "REAL-LIFE"-EXPERIENCE WITH 2ND GENERATION DIRECTACTING ANTIVIRAL (DAA) TREATMENT IN HCV PATIENTS (N=207)
    Werner, C. R.
    Malek, N.
    Lauer, U.
    Berg, C.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S752 - S753
  • [7] Treatment of Hepatocellular Carcinoma with Immune Checkpoint Inhibitors and Applicability of First-Line Atezolizumab/Bevacizumab in a Real-Life Setting
    Torres, Maria Corina Plaz
    Lai, Quirino
    Piscaglia, Fabio
    Caturelli, Eugenio
    Cabibbo, Giuseppe
    Biasini, Elisabetta
    Pelizzaro, Filippo
    Marra, Fabio
    Trevisani, Franco
    Giannini, Edoardo G.
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (15)
  • [8] Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies
    Di Maio, Velia C.
    Cento, Valeria
    Lenci, Ilaria
    Aragri, Marianna
    Rossi, Piera
    Barbaliscia, Silvia
    Melis, Michela
    Verucchi, Gabriella
    Magni, Carlo F.
    Teti, Elisabetta
    Bertoli, Ada
    Antonucci, FrancescoPaolo
    Bellocchi, Maria C.
    Micheli, Valeria
    Masetti, Chiara
    Landonio, Simona
    Francioso, Simona
    Santopaolo, Francesco
    Pellicelli, Adriano M.
    Calvaruso, Vincenza
    Gianserra, Laura
    Siciliano, Massimo
    Romagnoli, Dante
    Cozzolongo, Raffaele
    Grieco, Antonio
    Vecchiet, Jacopo
    Morisco, Filomena
    Merli, Manuela
    Brancaccio, Giuseppina
    Di Biagio, Antonio
    Loggi, Elisabetta
    Mastroianni, Claudio M.
    Palitti, Valeria Pace
    Tarquini, Pierluigi
    Puoti, Massimo
    Taliani, Gloria
    Sarmati, Loredana
    Picciotto, Antonino
    Vullo, Vincenzo
    Caporaso, Nicola
    Paoloni, Maurizio
    Pasquazzi, Caterina
    Rizzardini, Giuliano
    Parruti, Giustino
    Craxi, Antonio
    Babudieri, Sergio
    Andreoni, Massimo
    Angelico, Mario
    Perno, Carlo F.
    Ceccherini-Silberstein, Francesca
    LIVER INTERNATIONAL, 2017, 37 (04) : 514 - 528
  • [9] The challenge of HCV-retreatment after DAA-failure: Italian real-life from VIRONET-C network
    Cento, V.
    Barbaliscia, S.
    Di Maio, V. C.
    Masetti, C.
    Minichini, C.
    Magni, C. F.
    Micheli, V.
    Marenco, S.
    Nicolini, L. A.
    Bruzzone, B.
    Troshina, Y.
    Baiguera, C.
    Dentone, C.
    Calvaruso, V.
    Paolucci, S.
    Melis, M.
    Aragri, M.
    Bertoli, A.
    Lenci, I.
    Landonio, S.
    Schiavini, M.
    Sticchi, L.
    Ruggiero, T.
    Polilli, E.
    Messina, V.
    Pellicelli, A.
    Boglione, L.
    Cozzolongo, R.
    Biolato, M.
    Morisco, F.
    Siciliano, M.
    Parruti, G.
    Barbarini, G.
    Craxi, A.
    Babudieri, S.
    Puoti, M.
    Ciancio, A.
    Rizzardini, G.
    Coppola, N.
    Angelico, M.
    Perno, C. F.
    Ceccherini-Silberstein, F.
    DIGESTIVE AND LIVER DISEASE, 2017, 49 (01) : E8 - E8
  • [10] CHRONIC HEPATITIS C TREATMENT WITH DIRECT-ACTING ANTIVIRAL AGENTS IN A REAL-LIFE SETTING
    Ann Chirino-Sprung, Ruby
    Dehesa, Margarita
    Wolpert, Enrique
    Corona-Lau, Clara
    Garcia-Juarez, Ignacio
    Francisco Sanchez-Avila, Jose
    Moctezuma-Velazquez, Carlos
    Kershenobich, David
    REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 2016, 68 (04): : 201 - 209